Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Political Updates Today.
Press releases published on May 5, 2025

Edge Zero Launches Grid Visibility Solution to Support Labor Party’s Home Battery Initiative
New program equips distribution system operators with real-time data tools to ensure network readiness for Australia’s largest-ever home battery rollout MELBOURNE, VIC, AUSTRALIA, May 6, 2025 /EINPresswire.com/ -- Edge Zero, a leader in low-voltage (LV) …

Javier Palomarez, USHBC President, Commends Virginia for Leading the Nation in Reducing Fentanyl Overdoses
WASHINGTON DC, DC, UNITED STATES, May 5, 2025 /EINPresswire.com/ -- The United States Hispanic Business Council (USHBC) commends Virginia Governor Glenn Youngkin and First Lady Suzanne S. Youngkin for tackling the fentanyl crisis head-on through a …

The Pan African Film & Arts Festival Announces Call for Submissions for 2026 Festival
The largest international Black film festival in the U.S. returns to Los Angeles February 9–16, 2026 LOS ANGELES, CA, UNITED STATES, May 5, 2025 /EINPresswire.com/ -- The Pan African Film …

VetComm Honors Military Appreciation Month by Empowering Veterans to Access Their VA Disability Benefits
Veteran-founded organization provides guidance and advocacy to help veterans navigate the VA benefits process during Military Appreciation Month and beyond. SAN DIEGO, CA, UNITED STATES, May 5, 2025 /EINPresswire.com/ -- As the nation observes Military …

AMMWEC to Host Capitol Hill Event: "Towards a Broader Abraham Accords: Embracing Asia's Potential"
WASHINGTON, DC, UNITED STATES, May 5, 2025 /EINPresswire.com/ -- The American Muslim …

First 5 California Welcomes Anthony Pane as New Chief Counsel
First 5 California proudly announces the appointment of Anthony Pane as its new Chief Counsel. SACRAMENTO, CA, UNITED STATES, May 5, 2025 /EINPresswire.com/ -- First 5 California proudly announces the appointment of Anthony Pane as its new Chief Counsel …

Veteran M&A Attorney Joins Spiro Harrison & Nelson to Lead Corporate Business Transactions Practice Group
Spiro Harrison …

NCLA Opposes Transfer of Expanded Lawsuit Against Trump Administration’s Unlawful Tariffs
Washington, DC, May 05, 2025 (GLOBE NEWSWIRE) -- The New Civil Liberties Alliance filed an Amended Complaint today adding several Plaintiffs to the Simplified v. Trump, et al. lawsuit against President Trump’s attempt to rely on the International Emergency …

DBV Technologies to Participate in the Citizens JMP Life Sciences Conference
Châtillon, France, May 5, 2025 DBV Technologies to Participate in the Citizens JMP Life Sciences Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced …

DBV Technologies participera à la conférence Citizens JMP Life Sciences
Châtillon, France, le 5 mai (22 :30 CEST) 2025 DBV Technologies participera à la conférence Citizens JMP Life Sciences DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market : DBVT), société biopharmaceutique en phase clinique, …

After Clergy Arrested for Praying, Moral Monday Returns to U.S. Supreme Court to Confront Deadly Federal Budget
Faith leaders and impacted people to hold prayerful protest calling out a budget that will kill Medicaid, starve children, and abandon the poor WASHINGTON DC, DC, UNITED STATES, May 5, 2025 /EINPresswire.com/ -- On Monday, May 5, 2025, at 11:00 AM ET, a …

OSE Immunotherapeutics Announces >90% of Responders Maintained Symptomatic Remission Through Extension Period on Lusvertikimab
OSE Immunotherapeutics Announces >90% of Responders Maintained Symptomatic Remission Through Extension Period on Lusvertikimab Lusvertikimab well tolerated over the 24-week additional treatment period. Oral presentation at DDW 2025 of clinical data from …

OSE Immunotherapeutics annonce que plus de 90% des patients répondeurs ont maintenu une rémission symptomatique pendant la période d’extension sous Lusvertikimab
OSE Immunotherapeutics annonce que plus de 90 % des patients répondeurs ont maintenu une rémission symptomatique pendant la période d’extension sous Lusvertikimab Bonne tolérance de Lusvertikimab pendant les 24 semaines supplémentaires de traitement. …

Transaction in Own Shares
Transaction in Own Shares 5 May, 2025 • • • • • • • • • • • • • • • • Shell plc (the ‘Company’) announces that on 5 May, 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading …

AB Science will present new data from masitinib clinical program in ALS in two presentations at the 2025 ENCALS Annual Meeting
PRESS RELEASE AB SCIENCE TO PRESENT NEW DATA FROM MASITINIB CLINICAL PROGRAM IN AMYOTROPHIC LATERAL SCLEROSIS IN TWO PRESENTATIONS AT THE 2025 ENCALS ANNUAL MEETING MASITINIB REDUCES SERUM NEUROFILAMENT LIGHT CHAIN (NFL) LEVELS, SUGGESTING THAT IT HAS …

AB Science présentera lors de la réunion annuelle de l’ENCALS en 2025 de nouvelles données issues du programme de développement clinique du masitinib dans la SLA
COMMUNIQUE DE PRESSE AB SCIENCE PRÉSENTERA LORS DE LA RÉUNION ANNUELLE DE L'ENCALS EN 2025 DE NOUVELLES DONNÉES ISSUES DU PROGRAMME DE DEVELOPPEMENT CLINIQUE DU MASITINIB DANS LA SCLÉROSE LATÉRALE AMYOTROPHIQUE LE MASITINIB RÉDUIT LA CONCENTRATION SERIQUE …

RUBIS: Q1 2025 trading update - Continued strong operating performance of Rubis’ diversified business model
Paris, 5 May 2025, 5:45pm Energy Distribution Retail …

RUBIS: Activité du premier trimestre 2025 - Nouveau trimestre de performance opérationnelle solide du modèle diversifié
Paris, le 5 mai 2025, 17h45 Distribution d'énergies Retail …

Coface : Coface records a good start to the year with net income of €62.1m, for an RoATE of 12.7%
Coface records a good start to the year with net income of €62.1m, for an RoATE of 12.7% Paris, 5 May 2025 – 17.35 Turnover: €473m, up 2.0% at constant FX and perimeter Trade credit insurance revenue up 1.2%; client activity also increased by 1.2% Client …

Coface : Coface enregistre un bon début d’année avec un résultat net de 62,1 M€, soit un RoATE de 12,7%
Coface enregistre un bon début d’année avec un résultat net de 62,1 M€, soit un RoATE de 12,7% Paris, le 5 mai 2025 – 17h35 Chiffre d’affaires : 473 M€, en hausse de 2,0% à périmètre et taux de change constants Les primes d’assurance-crédit sont en hausse …